⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23735556 | 0.87 | NPSR1 (0.33) | — | |
| SCHEMBL23735557 | 0.81 | NPSR1 (0.38) | — | |
| SCHEMBL23735559 | 0.78 | KMT2A (0.43) | — | |
| SCHEMBL606948 | 0.73 | — | — | |
| SCHEMBL12601053 | 0.73 | — | — | |
| SCHEMBL21525749 | 0.73 | — | — | |
| SCHEMBL8320412 | 0.71 | — | — | |
| SCHEMBL25143645 | 0.71 | — | — | |
| SCHEMBL15224096 | 0.71 | — | — | |
| SCHEMBL228058 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348516-A1 | YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | MOLECURE S.A. (PL) | 2023-11-02 | — | — | US | claimed |
| EP-4269400-A1 | YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | Molecure SA (PL) | 2023-11-01 | — | — | EP | claimed |
| CN-116655542-A | Dihydro quinolinone derivative, preparation method and application | 中山大学 | 2023-08-29 | — | — | CN | claimed |
| EP-3428229-B1 | CURABLE RESIN COMPOSITION, FUEL CELL, AND SEALING METHOD | THREE BOND CO LTD (JP) | 2022-08-17 | — | — | EP | claimed |
| CN-112567240-A | Method for determining moisture content in sample using imidazole derivative and hydrogen halide donor | 霍尼韦尔国际公司 | 2021-03-26 | — | — | CN | claimed |
| US-10800952-B2 | Curable resin composition, fuel cell, and sealing method | THREEBOND CO., LTD. (JP) | 2020-10-13 | — | — | US | claimed |
| US-20260138359-A1 | SILICONE-THERMOPLASTIC COMPOSITE ARTICLES | DOW SILICONES CORP (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260109818-A1 | LIQUID SILICONE RUBBER COMPOSITION | DOW SILICONES CORP (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260098144-A1 | RESIN COMPOSITION, FILM WITH RESIN, PREPREG, SHEET OF METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2026-04-09 | — | — | US | disclosed |
| EP-4590757-A1 | LIQUID SILICONE RUBBER COMPOSITION | Dow Silicones Corporation (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4590760-A1 | SILICONE-THERMOPLASTIC COMPOSITE ARTICLES | Dow Silicones Corporation (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4590759-A1 | SILICONE-THERMOPLASTIC COMPOSITE ARTICLES | Dow Silicones Corporation (US) | 2025-07-30 | — | — | EP | disclosed |
| CN-119998377-A | Liquid silicone rubber composition | 美国陶氏有机硅公司 | 2025-05-13 | — | — | CN | disclosed |
| WO-2006109026-A1 | 4-(PYRID-2-YL) AMINO SUBSTITUTED PYRIMIDINE AS PROTEIN KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2006-10-19 | — | — | WO | disclosed |
| WO-2006106307-A1 | PYRIMIDINE DERIVATIVES FOR USE AS ANTICANCER AGENTS | ASTRAZENECA AB (SE) | 2006-10-12 | — | — | WO | disclosed |
| WO-2006106306-A1 | PYRIMIDINES AS IGF-I INHIBITORS | ASTRAZENECA AB (SE) | 2006-10-12 | — | — | WO | disclosed |
| WO-2006100461-A1 | 2-AZETIDINYL-4-(lH-PYRAZOL-3-YLAMINO)PYRIMIDINES AS INHIBITORS OF INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ACTIVITY | ASTRAZENECA AB (SE) | 2006-09-28 | — | — | WO | disclosed |
| EP-1678169-A1 | 4-(PYRAZOL-3-YLAMINO)PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | Astrazeneca AB (SE) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005040159-A1 | 4-(PYRAZOL-3-YLAMINO) PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2005-05-06 | — | — | WO | disclosed |
| EP-0005051-B1 | 4-DESACETYL VLB C-3 CARBOXHYDRAZIDES, THEIR PREPARATION AND FORMULATIONS CONTAINING THEM | ELI LILLY AND COMPANY (US) | 1982-12-01 | — | — | EP | disclosed |